Pharmaceutical composition for treating chronic kidney disease
AssigneesShionogi & Co., Ltd., Keio University
InventorsTakashi Ono, Katsutoshi Yamada, Norito Yoshimura, Toshihiro Shinosaki, Yoshinari Gahara, Hiroshi Itoh, Shu Wakino, Takeshi Kanda, Kazuhiro Hasegawa, Motoaki Komatsu
Life of this patent
Estimating the term…
Abstract
This invention is related to a therapeutic agent for treating chronic kidney disease comprising a substance which inhibits the enzymatic activity of NNMT or suppresses NNMT gene expression, or a method for screening a therapeutic agent for treating chronic kidney disease which targets the NNMT enzyme or NNMT gene.
Claims3
A method of treatment comprising a step of administering a substance inhibiting the enzymatic activity of nicotinamide N-methyltransferase (NNMT) or suppressing NNMT gene expression for treating chronic kidney disease.
Dependencies are inferred from the claim text.